Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Year: 2014
Type: article
Source: The Lancet
Authors: Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M Swain, Tatiana Prowell, Sibylle Loibl, D Lawrence Wickerham, Jan Bogaerts, Jose Baselga, Charles Perou, Gideon Blumenthal, Jens Blohmer, Eleftherios P Mamounas, Jonas Bergh, Vladimir Semiglazov, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, Wolfgang Eiermann, Gunter von Minckwitz
Institutions: United States Food and Drug Administration, Helios Kliniken, German Breast Group, NSABP Foundation, Université de Bordeaux, Inserm, Institut Bergonié, Université Bordeaux Segalen, NHS Lothian, Edinburgh Cancer Research, University of Edinburgh, IRCCS Ospedale San Raffaele, Fondazione Michelangelo, MedStar Washington Hospital Center, European Organisation for Research and Treatment of Cancer, Memorial Sloan Kettering Cancer Center, UNC Lineberger Comprehensive Cancer Center, Sankt Gertrauden Krankenhaus, Karolinska University Hospital, Karolinska Institutet, Institute of Oncology NN Petrov, University Hospital Schleswig-Holstein, Institut Jules Bordet, Universitätsklinikum Erlangen, Universitätsmedizin Rostock, VCU Massey Comprehensive Cancer Center, Ludwig-Maximilians-Universität München
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Awards: G1261401763, G2102466906
OpenAlex ID: W2075894019